Paweł Krawczyk

8PUBLICATIONS
32CO-AUTHORS
Cancer cell biologyMolecular targetsImmunogenetics (incl. genetic immunology)Medical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 25, 2025
Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review.

Kamil Kośmider, Agata Kozakiewicz, Paweł Krawczyk

|Jan 20, 2025
Emerging insights into STK11, KEAP1 and KRAS mutations: implications for immunotherapy in patients with advanced non-small cell lung cancer.

Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk, Paweł Krawczyk

|Mar 10, 2023
Effectiveness of ALK inhibitors in treatment of CNS metastases in NSCLC patients.

Michał Gil, Magdalena Knetki-Wróblewska, Przemysław Niziński

|Oct 23, 2021
Crizotinib efficacy in advanced non-squamous NSCLC patients with ALK or ROS1 rearrangement.

Paweł Krawczyk, Anna Grenda, Paulina Terlecka

Pageof 2